Objective:To observe the efficacy and safety of Etiasa, a control released tablet of mesalazine, in treatment of inflammatory bowel disease(IBD) in comparison with salicylazosulfapyridine (SASP).

目的：观察一种新型美沙拉嗪控释剂（艾迪莎）治疗炎症性肠病（IBD）的疗效和安全性，并同水杨酸偶氮磺胺吡啶（SASP）进行比较。

youdao

Objective:To observe the efficacy and safety of Etiasa, a control released tablet of mesalazine, in treatment of inflammatory bowel disease(IBD) in comparison with salicylazosulfapyridine (SASP).

目的：观察一种新型美沙拉嗪控释剂（艾迪莎）治疗炎症性肠病（IBD）的疗效和安全性，并同水杨酸偶氮磺胺吡啶（SASP）进行比较。

youdao